…normal brain cells. The study is being conducted at the Dana-Farber Cancer Institute in Boston, Massachusetts and is being led by Dr David Reardon, Clinical Director, Center for Neuro-Oncology. “Dosing…

A stem cell derived investigational therapy for treating Parkinson’s disease has shown promise in early clinical trials. BlueRock Therapeutics, a subsidiary of Bayer, has announced details of the positive data…

…cell lines with the functionality and normal karyotype of primary hepatocytes. Human induced pluripotent stem cell-derived hepatocyte-like cells (HLCs) have the potential to fulfil this role. In this webinar you…

…represent the gold standard in vitro cell model for functionality. However, when isolated from liver tissue, primary cells maintain expression of key proteins for only a short period. Extending culture…

…cells at clearing the toxic proteins or by ‘honing’ the immune response to these proteins so that ‘collateral damage’ to nearby healthy brain cells is decreased. Of course, these vaccines…

…form on bacterial membranes and not on human membranes, they are presumably also the reason why Clovibactin selectively damages bacterial cells but is not toxic to human cells,” says Weingarth….

…as the nucleus tractus solitarius, which is linked to addiction, and also act on the mesolimbic pathway, a dopamine-based system that regulates responses to rewarding stimuli like drugs and food….

…A new study has demonstrated that machine learning can accurately predict subtypes of Parkinson’s disease using images of patient-derived stem cells, paving the way for personalised medicine and targeted drug…

…means they activate AHR to target a number of genes. Some of the genes targeted switch off the AHR system, allowing it to self-regulate. The researchers showed that when mice…

…pluripotent stem cells (hiPSCs), which are derived from adult, non-reproductive cells that have been genetically reprogrammed. “This is a new chapter in human physiology.” The tiny model has multiple chambers,…

…increase the numbers of lymphocytes (white blood cells) in the blood. Further studies in mouse models of arthritis showed that therapeutic administration of Ab-IPL-IL-17 is as effective at halting disease…

A new study has demonstrated that machine learning can accurately predict subtypes of Parkinson’s disease using images of patient-derived stem cells, paving the way for personalised medicine and targeted drug…

…Lentivirus Physical and Proviral DNA Titer Kits with the QuantStudio Absolute QDigital PCR System Measurement of lentiviral vector titers and provirus copies in transduced cells by digital PCR Long terminal…

Researchers have shown that a group of novel molecules inspired by our own immune system inactivates viruses like Zika and chikungunya, and could help overcome antiviral resistance. “We found an…

…of prostaglandin receptor, the prostaglandin E2 (PGE2)-type prostanoid receptor 4 (EP4). In cancer, PGE2 acts in the tumour microenvironment to trigger cancer cells to evade the immune system. Targeting EP4…

A new study has shown that blood thinner warfarin could also treat cancer, as it stops tumours from interfering with a self-destruct mechanism that cells initiate when they detect mutations…